Breaking News/May 28, 2026, 10:45 AM

CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash - NBC News

CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash NBC News CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans CNBC CVS Returns Zepbound to Drug Plans After Lilly Slashes Price Bloomberg CVS Caremark adds Zepbound and Foundayo to formulary qz.com CVS brings back coverage for Lilly's obesity drug Zepbound Reuters

YesNo saves this item as an on-site live signal so search users can understand how it connects to prediction markets and incubation topics.

If later reporting creates a clear deadline, official source, or verifiable outcome, the public event can become a tradable Yes/No question.

Prediction signal

This item has a verifiable event angle that can be monitored for a Yes/No prediction market.

Signal score

Event type

science_health